US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Veradermics, Inc.

126.63

+15.6814.13%

Post-market: 126.00-0.6300-0.50%19:56 EDT

Volume:3.49M

Turnover:442.93M

Market Cap:5.29B

PE:-19.65

High:136.72

Open:111.60

Low:110.56

Close:110.95

52wk High:136.72

52wk Low:32.00

Shares:41.78M

Float Shares:32.29M

Volume Ratio:5.48

T/O Rate:10.81%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-6.4439

EPS(LYR):-111.9114

ROE:-72.06%

ROA:-43.45%

PB:6.50

PE(LYR):-1.13

Loading ...

Overview Company News Filings

Looking to Regrow Hair? New Options Are on the Horizon -- WSJ

Is It Too Late To Consider Veradermics (MANE) After A 162% Year To Date Surge?

Simply Wall St.

BUZZ-U.S. STOCKS ON THE MOVE-Quanta, O'Reilly Automotive, Avis

BUZZ-Veradermics climbs, then eases after upsized $414 mln equity offering

Veradermics Prices Upsized Public Offering, Enters Private Placement

MT Newswires Live

Veradermics 3.84M share Secondary priced at $100.00

BRIEF-Veradermics Announces Pricing Of Upsized Public Offering And Private Placement

Veradermics prices $30 million private placement of pre-funded warrants with Suvretta Capital affiliates

Veradermics Inc - Announces Upsized Public Offering of 3,843,790 Shares at $100.00 per Share

THOMSON REUTERS

Veradermics Hair Loss Trial Success Spurs Funding Plans For VDPHL01

Simply Wall St.

BUZZ-U.S. STOCKS ON THE MOVE-Enterprise Products, Sherwin-Williams, Veradermics

Stock Track | Veradermics Soars 5.55% Intraday After Citigroup Raises Target Price to $120

BUZZ-Veradermics falls after launching follow-on stock sale

Veradermics announces offering of 3.35M shares of common stock

Veradermics launches public offering of 3,350,000 common shares, pre-funded warrants

Veradermics Announces Launch of Public Offering

THOMSON REUTERS

Veradermics Inc: Has Launched Proposed Public Offering of 3.4 Mln Shares of Common Stock

THOMSON REUTERS

Veradermics files to sell 3.35M shares of common stock

Small U.S. Stocks Finish Mixed As Veradermics Leads, POET Technologies Lags

Veradermics price target raised to $120 from $85 at Citi

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/MANE/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MANE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","market":"US","secType":"STK","nameCN":"Veradermics, Inc.","latestPrice":126.63,"timestamp":1791489600000,"preClose":110.95,"halted":0,"volume":3490511,"hourTrading":{"tag":"盘后","latestPrice":126,"preClose":126.63,"latestTime":"19:56 EDT","volume":6110,"amount":773199.2667,"timestamp":1791503816611,"change":-0.63,"changeRate":-0.004975,"amplitude":0.00598},"delay":0,"changeRate":0.14132492113564663,"floatShares":32290700,"shares":41778687,"eps":-6.443948,"marketStatus":"Not Yet Opened","change":15.68,"latestTime":"10-08 16:00:00 EDT","open":111.6,"high":136.715,"low":110.56,"amount":442931046.13335997,"amplitude":0.235737,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.443948,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791532800000},"marketStatusCode":0,"adr":0,"listingDate":1770181200000,"exchange":"NYSE","adjPreClose":110.95,"preHourTrading":{"tag":"盘前","latestPrice":111.6,"preClose":110.95,"latestTime":"09:29 EDT","volume":3804,"amount":423629.54994,"timestamp":1791466199999,"change":0.65,"changeRate":0.005858,"amplitude":0.037855},"postHourTrading":{"tag":"盘后","latestPrice":126,"preClose":126.63,"latestTime":"19:56 EDT","volume":6110,"amount":773199.2667,"timestamp":1791503816611,"change":-0.63,"changeRate":-0.004975,"amplitude":0.00598},"volumeRatio":5.476679,"impliedVol":1.2597,"impliedVolPercentile":0.9836},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MANE\",,,,,undefined,":{"symbol":"MANE","floatShares":32290700,"roa":"-43.45%","roe":"-72.06%","lyrEps":-111.911419,"volumeRatio":5.476679,"shares":41778687,"dividePrice":0,"high":136.715,"amplitude":0.235737,"preClose":110.95,"low":110.56,"week52Low":32,"pbRate":"6.50","week52High":136.715,"institutionHeld":0,"latestPrice":126.63,"eps":-6.443948,"divideRate":0,"volume":3490511,"delay":0,"ttmEps":-6.443948,"open":111.6,"prevYearClose":17,"prevWeekClose":116.76,"prevMonthClose":121.23,"prevQuarterClose":121.23,"fiveDayClose":117.22,"twentyDayClose":98.14,"sixtyDayClose":123.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MANE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"MANE","fiscalQuarterEnding":"2026/06","expectedEps":-0.58,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.58}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MANE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MANE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1784174400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MANE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MANE","date":"2026-10-07","current":-19.650997,"percent":0.431953,"low":-67.545361,"twenty":-53.643529,"median":-47.365301,"eighty":-35.571997,"high":-9.296992,"avg":-45.829099,"sd":10.305782,"marketCap":4552363618},"quantilePoints":[{"date":"2026-02-06","current":-25.786263,"twenty":-25.079893,"median":-17.8457,"eighty":-10.368249,"marketCap":1387507243},{"date":"2026-02-13","current":-30.838039,"twenty":-29.065754,"median":-25.786263,"eighty":-19.198356,"marketCap":1659333205},{"date":"2026-02-20","current":-33.530469,"twenty":-32.062123,"median":-28.069277,"eighty":-25.043809,"marketCap":1804207481},{"date":"2026-02-27","current":-29.776333,"twenty":-31.085076,"median":-29.967163,"eighty":-25.732137,"marketCap":1602204947},{"date":"2026-03-06","current":-33.738647,"twenty":-32.654736,"median":-30.560469,"eighty":-26.152655,"marketCap":1815409101},{"date":"2026-03-13","current":-35.785726,"twenty":-33.721993,"median":-31.049686,"eighty":-27.249057,"marketCap":1925558357},{"date":"2026-03-20","current":-39.491287,"twenty":-35.53175,"median":-31.816474,"eighty":-28.546698,"marketCap":2124947181},{"date":"2026-03-27","current":-46.874652,"twenty":-39.507941,"median":-32.867771,"eighty":-29.468231,"marketCap":2522231279},{"date":"2026-04-02","current":-31.356106,"twenty":-39.513493,"median":-32.867771,"eighty":-29.852665,"marketCap":2194770608},{"date":"2026-04-10","current":-31.99758,"twenty":-38.92088,"median":-32.857362,"eighty":-30.17702,"marketCap":2239670594},{"date":"2026-04-17","current":-39.540857,"twenty":-39.536494,"median":-33.608872,"eighty":-30.279902,"marketCap":2767662294},{"date":"2026-04-24","current":-36.942854,"twenty":-39.536494,"median":-33.738647,"eighty":-30.421684,"marketCap":2585815082},{"date":"2026-05-01","current":-52.813611,"twenty":-40.831905,"median":-34.49692,"eighty":-30.615983,"marketCap":3696688710},{"date":"2026-05-08","current":-63.45616,"twenty":-42.963163,"median":-35.411007,"eighty":-30.844978,"marketCap":4441613943},{"date":"2026-05-15","current":-51.496667,"twenty":-46.59847,"median":-35.988193,"eighty":-30.890717,"marketCap":4368307751},{"date":"2026-05-22","current":-50.831536,"twenty":-50.412067,"median":-36.702792,"eighty":-31.015444,"marketCap":4311886693},{"date":"2026-05-29","current":-50.670085,"twenty":-50.670085,"median":-37.508333,"eighty":-31.226637,"marketCap":4298191318},{"date":"2026-06-05","current":-49.857433,"twenty":-50.482929,"median":-39.295461,"eighty":-31.282151,"marketCap":4229256485},{"date":"2026-06-12","current":-46.493546,"twenty":-50.049515,"median":-39.519044,"eighty":-31.356106,"marketCap":3943908052},{"date":"2026-06-18","current":-45.24748,"twenty":-50.006173,"median":-40.004977,"eighty":-31.7244,"marketCap":3838207974},{"date":"2026-06-26","current":-58.79168,"twenty":-50.634624,"median":-40.906894,"eighty":-31.961359,"marketCap":4987121867},{"date":"2026-07-02","current":-63.278505,"twenty":-51.067836,"median":-42.661209,"eighty":-32.20951,"marketCap":5367725705},{"date":"2026-07-10","current":-61.520221,"twenty":-53.048338,"median":-44.057315,"eighty":-32.416525,"marketCap":5218575793},{"date":"2026-07-17","current":-52.123009,"twenty":-54.2625,"median":-44.976596,"eighty":-32.698555,"marketCap":4421438445},{"date":"2026-07-24","current":-57.062948,"twenty":-54.490042,"median":-45.472923,"eighty":-32.869852,"marketCap":4840478675},{"date":"2026-07-31","current":-51.531989,"twenty":-54.856474,"median":-45.794173,"eighty":-33.139095,"marketCap":4371304020},{"date":"2026-08-07","current":-53.511905,"twenty":-54.832834,"median":-46.684099,"eighty":-33.593192,"marketCap":4539254342},{"date":"2026-08-14","current":-50.036631,"twenty":-54.832834,"median":-47.316049,"eighty":-33.69117,"marketCap":4637595096},{"date":"2026-08-21","current":-47.476198,"twenty":-54.602336,"median":-47.561116,"eighty":-33.713665,"marketCap":4400283923},{"date":"2026-08-28","current":-45.893958,"twenty":-54.263485,"median":-47.316049,"eighty":-33.861631,"marketCap":4253635646},{"date":"2026-09-04","current":-44.06379,"twenty":-54.197488,"median":-46.684099,"eighty":-34.12449,"marketCap":4084008294},{"date":"2026-09-11","current":-44.239594,"twenty":-54.067463,"median":-46.421397,"eighty":-34.344005,"marketCap":4100302547},{"date":"2026-09-18","current":-48.99082,"twenty":-53.916605,"median":-46.349247,"eighty":-34.830885,"marketCap":4540665180},{"date":"2026-09-25","current":-52.164315,"twenty":-53.806823,"median":-46.818058,"eighty":-35.200053,"marketCap":4834797337},{"date":"2026-10-02","current":-52.840485,"twenty":-53.806823,"median":-47.237246,"eighty":-35.451255,"marketCap":4897467541},{"date":"2026-10-07","current":-49.117039,"twenty":-53.643529,"median":-47.365301,"eighty":-35.571997,"marketCap":4552363618}],"updateTime":1791523019414},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MANE\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2632645890","title":"Looking to Regrow Hair? New Options Are on the Horizon -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2632645890","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632645890?lang=en_us&edition=fundamental","pubTime":"2026-05-01 23:45","pubTimestamp":1777650300,"startTime":"0","endTime":"0","summary":"For the first time in nearly three decades, new treatments may be on the way for the roughly 80 million Americans who are losing their hair.Experimental drugs are showing promise after years of little innovation. Earlier this week, New Haven, Conn.-based Veradermics reported promising late-stage trial results for a new hair-loss pill that is being developed for men and women. It is the latest in a string of hopeful results from companies developing new hair-loss treatments.Veradermics's drug is a new formulation of minoxidil. The pill is engineered for slow, steady absorption throughout the day rather than the rapid spikes that have been linked to cardiac risks.\"This is a population that is highly motivated but is deeply frustrated, \" said Reid Waldman, Veradermics's chief executive officer and a dermatologist, who attributed the recent surge in hair-loss innovation partly to a cultural shift driven by GLP-1 weight-loss drugs, which showed patients will pay out of pocket for treatments","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632615320","title":"Is It Too Late To Consider Veradermics (MANE) After A 162% Year To Date Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2632615320","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632615320?lang=en_us&edition=fundamental","pubTime":"2026-05-01 17:48","pubTimestamp":1777628927,"startTime":"0","endTime":"0","summary":"Wondering if Veradermics at around US$99 a share still lines up with the story you have in mind, or if the price is already baking in a lot of optimism.\nThe stock has seen sharp recent moves, with returns of 43% over the last 7 days, 56.8% over the last 30 days, and 162.3% year to date. This can change how you think about both risk and potential reward.\nRecent headlines around Veradermics have focused on its position in the pharmaceuticals space and investor interest in its prospects,...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-mane/veradermics/news/is-it-too-late-to-consider-veradermics-mane-after-a-162-year","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-mane/veradermics/news/is-it-too-late-to-consider-veradermics-mane-after-a-162-year","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","DCF","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632577996","title":"BUZZ-U.S. STOCKS ON THE MOVE-Quanta, O'Reilly Automotive, Avis","url":"https://stock-news.laohu8.com/highlight/detail?id=2632577996","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632577996?lang=en_us&edition=fundamental","pubTime":"2026-05-01 01:40","pubTimestamp":1777570847,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Quanta, O'Reilly Automotive, AvisWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslett","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nL6N41D0UO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","AU","INHD","PSUS","RDAC","LH","CLB","MSFT","LLY","MO","TXT","MANE","CAT","CVNA","F","BAX","TER","IP","MAX","GOOGL","HAO","AKAN","CAH","KLAC","RCL","WTW","RDACU","HTZ","PACK","AMKR","AMRZ","CARR","IRM","QCOM","GKOS","PWR","HCAI","OWL","CAR","AMZN","ORLY","OSRH","VLN","INTC","CTSH","COP","META","NEM","CBZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631656911","title":"BUZZ-Veradermics climbs, then eases after upsized $414 mln equity offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2631656911","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631656911?lang=en_us&edition=fundamental","pubTime":"2026-04-30 22:33","pubTimestamp":1777559591,"startTime":"0","endTime":"0","summary":"BUZZ-Veradermics climbs, then eases after upsized $414 mln equity offering** Shares of dermatologist-founded biopharma Veradermics MANE.N down 3.6% at $102.74 on Thurs after increased follow-on priced","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nL6N41D175:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0052756011.USD","LU0072461881.USD","LU0310800965.SGD","LU2236285917.USD","LU2417539215.USD","BK4504","BK4588","LU0098860793.USD","LU0106831901.USD","BK4207","BK4585","LU0477156953.USD","LU1201861249.SGD","LU1244550494.USD","LU2456880835.USD","LU1267930227.SGD","LU0130517989.USD","LU2125154935.USD","LU1791807156.HKD","LU2360032135.SGD","LU1244550221.USD","LU0162691827.USD","LU0128525689.USD","LU0170899867.USD","LU2462157665.USD","BK4127","LU1506573853.SGD","IE00BSNM7G36.USD","LU0314106906.USD","LU0980610538.SGD","BK4007","LU0648001328.SGD","LU1668664300.SGD","LU1366192091.USD","BK4534","LU0320765646.SGD","LU1162221912.USD","LU1244550577.SGD","MANE","LU2125154778.USD","JEF","LU0130102774.USD","BK4566","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631685626","title":"Veradermics Prices Upsized Public Offering, Enters Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2631685626","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631685626?lang=en_us&edition=fundamental","pubTime":"2026-04-30 16:22","pubTimestamp":1777537335,"startTime":"0","endTime":"0","summary":"Veradermics (MANE) said late Wednesday it priced its upsized public offering of 3.8 million common shares at $100 per share for gross proceeds of about $384.4 million.The company has provided the unde","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631508391","title":"Veradermics 3.84M share Secondary priced at $100.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2631508391","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631508391?lang=en_us&edition=fundamental","pubTime":"2026-04-30 11:35","pubTimestamp":1777520114,"startTime":"0","endTime":"0","summary":"The deal size was increased to 3.84M shares from 3.35M and priced below last closing price of $106.55. Jefferies, Leerink, Citi and Cantor Fitzgera...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-3-84m-share-secondary-priced-at-100-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-3-84m-share-secondary-priced-at-100-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631572020","title":"BRIEF-Veradermics Announces Pricing Of Upsized Public Offering And Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2631572020","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631572020?lang=en_us&edition=fundamental","pubTime":"2026-04-30 10:32","pubTimestamp":1777516348,"startTime":"0","endTime":"0","summary":"BRIEF-Veradermics Announces Pricing Of Upsized Public Offering And Private PlacementApril 29 (Reuters) - Veradermics Inc MANE.N:VERADERMICS ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING AND PRIVATE PLA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUA7DTMQR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631720735","title":"Veradermics prices $30 million private placement of pre-funded warrants with Suvretta Capital affiliates","url":"https://stock-news.laohu8.com/highlight/detail?id=2631720735","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631720735?lang=en_us&edition=fundamental","pubTime":"2026-04-30 10:32","pubTimestamp":1777516336,"startTime":"0","endTime":"0","summary":"Veradermics priced a private placement of 300,000 pre-funded warrants to entities affiliated with Suvretta Capital.Warrants priced at USD 100 per share, reflecting USD 100 public offering price less USD 0.00001 exercise price.Gross proceeds expected at about USD 30 million before fees.Closing expected May 1, 2026; public offering closing not contingent on private placement.Securities sold in transaction not involving a public offering; not registered under Securities Act.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL3HKHFG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631029572","title":"Veradermics Inc - Announces Upsized Public Offering of 3,843,790 Shares at $100.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2631029572","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631029572?lang=en_us&edition=fundamental","pubTime":"2026-04-30 10:32","pubTimestamp":1777516320,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUA7DTMQR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631058274","title":"Veradermics Hair Loss Trial Success Spurs Funding Plans For VDPHL01","url":"https://stock-news.laohu8.com/highlight/detail?id=2631058274","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631058274?lang=en_us&edition=fundamental","pubTime":"2026-04-29 01:03","pubTimestamp":1777395801,"startTime":"0","endTime":"0","summary":"Veradermics (NYSE:MANE) reported positive topline data from its pivotal Phase 2/3 trial of VDPHL01, an investigational non-hormonal oral treatment for pattern hair loss.\nThe company framed VDPHL01 as a potential first in class oral option that could lead to the first FDA approval for a non-hormonal hair loss pill in nearly 30 years.\nFollowing the clinical update, Veradermics launched a proposed public offering tied to this stage of clinical and corporate progress.\n\nVeradermics focuses on...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-mane/veradermics/news/veradermics-hair-loss-trial-success-spurs-funding-plans-for","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-mane/veradermics/news/veradermics-hair-loss-trial-success-spurs-funding-plans-for","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MANE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630758913","title":"BUZZ-U.S. STOCKS ON THE MOVE-Enterprise Products, Sherwin-Williams, Veradermics","url":"https://stock-news.laohu8.com/highlight/detail?id=2630758913","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630758913?lang=en_us&edition=fundamental","pubTime":"2026-04-28 23:39","pubTimestamp":1777390791,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Enterprise Products, Sherwin-Williams, VeradermicsWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning N","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nL6N41B15S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNC","APA","ARM","ORCU","OXY","GM","XOMO","NVD2.UK","SPOT","CLYM","XOMX","UPS","SANM","SFD","UHS","AXGN","NVDS.UK","SBUX","JBLU","MANE","MUD","KMB","UGI","ERAS","AMD","BBBY","CVX","KO","DT","NEM","RMBS","AMGN","AMUU","ORCL","XOM","SNVD.UK","GLW","SHW","LFST","ZBH","NVDA","EPD","ALLE","XOMZ","MU","MUU","HLT","SBU","DPZ","ANV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183431036","title":"Stock Track | Veradermics Soars 5.55% Intraday After Citigroup Raises Target Price to $120","url":"https://stock-news.laohu8.com/highlight/detail?id=1183431036","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183431036?lang=en_us&edition=fundamental","pubTime":"2026-04-28 22:25","pubTimestamp":1777386344,"startTime":"0","endTime":"0","summary":"Veradermics, Inc. (MANE) saw its stock price soar 5.55% during intraday trading on Tuesday, reflecting strong investor interest in the pharmaceutical company.The surge follows an analyst upgrade from...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630334381","title":"BUZZ-Veradermics falls after launching follow-on stock sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2630334381","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630334381?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:42","pubTimestamp":1777326142,"startTime":"0","endTime":"0","summary":"BUZZ-Veradermics falls after launching follow-on stock sale** Shares of hair-restoration drug developer Veradermics MANE.N fall 3.6% to $96.50 in extended trading** MANE kicks off follow-on public offering of 3.35 million shares/pre-funded warrants; MANE had gone public in New York in February after upsized $256.3 million IPO. ** Concurrently with the offering, MANE expects to enter securities purchase agreement with certain entities affiliated with Suvretta Capital in a private placement. ** Stock closed up 47.6% on Monday at $100.10, roughly six times its IPO price of $17** MANE earlier on Monday reported positive latestage trial results for its experimental oral drug for pattern hair loss** Jefferies, Leerink Partners, Citigroup and Cantor acting as joint bookrunning managers for follow-on offering ** All four brokerages covering the stock rate it \"buy\" or higher; median PT is $85 - data compiled by LSEG** MANE will have 40.7 million outstanding shares after the offering, according ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nL4N41A226:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0162691827.USD","LU0320765646.SGD","LU1267930227.SGD","LU2125154935.USD","LU1506573853.SGD","LU1791807156.HKD","BK4504","LU0128525689.USD","BK4566","BK4534","LU0130102774.USD","LU0170899867.USD","LU0098860793.USD","LU1244550494.USD","LU0106831901.USD","LU0314106906.USD","LU2360032135.SGD","LU1244550577.SGD","LU0072461881.USD","BK4007","LU1244550221.USD","LU0477156953.USD","LU0310800965.SGD","LU1162221912.USD","MANE","IE00BSNM7G36.USD","LU0648001328.SGD","BK4588","LU2456880835.USD","BK4585","LU1668664300.SGD","LU2236285917.USD","BK4559","LU2417539215.USD","LU1366192091.USD","LU0052756011.USD","MNSH","LU0130517989.USD","LU2125154778.USD","LU1201861249.SGD","BK4207","LU0980610538.SGD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630343823","title":"Veradermics announces offering of 3.35M shares of common stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2630343823","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630343823?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:30","pubTimestamp":1777325415,"startTime":"0","endTime":"0","summary":"Veradermics (MANE) announced that it has launched a proposed public offering of 3.35M shares of common stock pursuant to a registration statement f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-announces-offering-of-3-35m-shares-of-common-stock-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-announces-offering-of-3-35m-shares-of-common-stock-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630834824","title":"Veradermics launches public offering of 3,350,000 common shares, pre-funded warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2630834824","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630834824?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:26","pubTimestamp":1777325184,"startTime":"0","endTime":"0","summary":"Veradermics launched proposed public offering of 3,350,000 shares of common stock, with pre-funded warrants offered in lieu of common stock to certain investors.Underwriters hold 30-day option to buy up to 502,500 additional shares.Company expects to enter securities purchase agreement to sell pre-funded warrants to entities affiliated with Suvretta Capital in a private placement.Public offering size will be reduced one-for-one for each pre-funded warrant sold in private placement, keeping total issuance at 3,350,000 securities.Jefferies, Leerink Partners, Citigroup, Cantor named joint bookrunners, with LifeSci as passive bookrunner.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veradermics Inc. published the original content used to ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL83ZNjk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE","LU0477156953.USD","BK4559","BK4566","LU2125154935.USD","LU2417539215.USD","BK4504","LU1244550221.USD","LU0170899867.USD","BK4534","LU0314106906.USD","MNSH","LU1267930227.SGD","LU1244550494.USD","LU2236285917.USD","LU1162221912.USD","LU0128525689.USD","BK4207","LU0098860793.USD","LU2456880835.USD","LU1791807156.HKD","LU0310800965.SGD","LU0162691827.USD","LU1244550577.SGD","IE00BSNM7G36.USD","LU0072461881.USD","LU1366192091.USD","LU0980610538.SGD","LU1201861249.SGD","LU0052756011.USD","LU0130517989.USD","BK4585","BK4007","LU0130102774.USD","LU0648001328.SGD","LU2462157665.USD","BK4588","LU1668664300.SGD","LU2360032135.SGD","LU1506573853.SGD","LU2125154778.USD","LU0106831901.USD","LU0320765646.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630482253","title":"Veradermics Announces Launch of Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2630482253","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630482253?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:26","pubTimestamp":1777325160,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA6LZZQM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630348216","title":"Veradermics Inc: Has Launched Proposed Public Offering of 3.4 Mln Shares of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2630348216","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630348216?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:26","pubTimestamp":1777325160,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA6LZZQM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630343386","title":"Veradermics files to sell 3.35M shares of common stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2630343386","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630343386?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:20","pubTimestamp":1777324843,"startTime":"0","endTime":"0","summary":"17:19 EDT Veradermics (MANE) files to sell 3.35M shares of common stock Published first on TheFly – the ultimate source for real-time, market-movin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-files-to-sell-3-35m-shares-of-common-stock-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-files-to-sell-3-35m-shares-of-common-stock-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630317234","title":"Small U.S. Stocks Finish Mixed As Veradermics Leads, POET Technologies Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2630317234","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630317234?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:21","pubTimestamp":1777321260,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies were mixed Monday, as the Russell 2000 Index closed flat, and the S&P Small Cap 600 Index was up 0.1%.Among companies with a market value of $1 billion to $6.7 billion, Veradermics Inc. was the best performer during the session, surging 48%, followed by Critical Metals Corp., which jumped 26%. Organon & Co. shares surged 17%, United States Antimony Corp. surged 15%, and shares of AEVEX Corp. Cl A jumped 14%.POET Technologies Inc. was the biggest laggard, dropping 47%, followed by shares of MaxLinear Inc., which dropped 14%. Shares of Willdan Group Inc. dropped 14%, PDF Solutions Inc. shares plunged 11%, and Erasca Inc. plunged 11%.Major U.S. stock indexes ended Monday mixed as the Nasdaq Composite Index increased 0.2%. Meanwhile, the S&P 500 Index added 0.1%, and the Dow Jones Industrial Average declined 0.1%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MANE","POET","BK4007","BK4141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630146543","title":"Veradermics price target raised to $120 from $85 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2630146543","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630146543?lang=en_us&edition=fundamental","pubTime":"2026-04-28 02:46","pubTimestamp":1777315581,"startTime":"0","endTime":"0","summary":"Citi raised the firm’s price target on Veradermics (MANE) to $120 from $85 and keeps a Buy rating on the shares after the company announced positiv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veradermics-price-target-raised-to-120-from-85-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veradermics-price-target-raised-to-120-from-85-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MANE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":114,"code":"91000000","status":"200"}]}}